BGBIO.OL Gross Margin

The Gross Margin of Bergenbio ASA (BGBIO.OL) is 100.00%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

BGBIO.OL Gross Margin - Historical Value

Date	Value
2024-12-31	100.00%

BGBIO.OL Gross Margin - Peers Comparison

Ticker	Name	Value
ALQGC.PA	Quantum Genomics SA	-14205.07%
LYTIX.OL	Lytix Biopharma AS	542.55%
SCLP.L	Scancell Holdings PLC	90.13%
ULTI.OL	Ultimovacs ASA	7775.20%
SIGHT.PA	Gensight Biologics SA	188.37%
SNG.L	Synairgen PLC	68.75%
BINV.ST	BioInvent International AB	42.37%
CANTA.ST	Cantargia AB	7775.20%
ETX.L	E-Therapeutics PLC	100.00%
ORPHA.CO	Orphazyme A/S	7775.20%
ALBPS.PA	Biophytis SA	7775.20%
IVACC.ST	Intervacc AB	-29.92%
VVY.AS	Vivoryon Therapeutics NV	85.42%
ALSEN.PA	Sensorion SA	7775.20%
HPHA.DE	Heidelberg Pharma AG	74.01%
POXEL.PA	Poxel SA	0.05%
SANION.ST	Saniona AB	85.03%
XSPRAY.ST	XSpray Pharma AB (publ)	2539.90%
AZT.OL	Arcticzymes Technologies ASA	94.27%
BVXP.L	Bioventix PLC	93.20%
DMYD B.ST	Diamyd Medical AB	-10161.54%
IVA.PA	Inventiva SA	146.31%
NANOV.OL	Nordic Nanovector ASA	7775.20%
PCIB.OL	PCI Biotech Holding ASA	100.00%
TILS.L	Tiziana Life Sciences PLC	63.16%
TRVX.OL	Targovax ASA	7775.20%
EXTX.OL	Exact Therapeutics AS	7775.20%
FARN.L	Faron Pharmaceuticals Oy	95.19%
HBC.OL	Hofseth Biocare ASA	34.13%
ORY.MC	Oryzon Genomics SA	-4700.00%
OSE.PA	OSE Immunotherapeutics SA	100.00%
ABVX.PA	Abivax SA	-19700.00%
MAB.WA	Mabion SA	75.54%
XBRANE.ST	Xbrane Biopharma AB	90.83%